Captor Therapeutics S.A. (CTX) — Cash Flow Reinvestment Rate
Captor Therapeutics S.A. (CTX) has a Cash Flow Reinvestment Rate of 1.94x as of March 2025, reinvesting zł44.69 Million (capex zł83.00K plus investments zł-44.60 Million) from operating cash flow of zł23.06 Million. Explore CTX cash flow metrics to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Captor Therapeutics S.A. Cash Flow Reinvestment Rate (2017–2019)
Historical reinvestment intensity for Captor Therapeutics S.A. across 2 annual periods. Explore Captor Therapeutics S.A. (CTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Captor Therapeutics S.A. (2017–2019)
Year-by-year capital reinvestment analysis for Captor Therapeutics S.A.. For live market cap and broader valuation context, see CTX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.10x | zł460.00K | zł4.39 Million | zł229.00K | — |
| 2017 | 0.00x | zł0.00 | zł2.10 Million | zł0.00 | — |